US2020093382A1PendingUtilityA1
Systems and methods for revascularization assessment
Est. expiryAug 14, 2033(~7 yrs left)· nominal 20-yr term from priority
A61B 5/7282A61B 5/0075A61B 5/7246A61B 5/02007A61B 5/6831A61B 5/6829A61B 5/0265A61B 5/0261A61B 5/726A61B 5/7257G16H 50/20A61B 5/6832
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed herein are systems and methods for revascularization assessment. The methods can in some cases include one or more of the steps of measuring blood perfusion as a function of time to obtain time series data, mathematically transforming the time series data into a power spectrum, calculating at least one parameter of the power spectrum within a specific frequency range, and using the at least one calculated parameter as a discriminator for the first population and the second population.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A computer-implemented method for discriminating between at least a first population and a second population, the method comprising:
measuring blood perfusion as a function of time to obtain time series data; mathematically transforming the time series data into a power spectrum; calculating at least one parameter of the power spectrum within a specific frequency range; and using the at least one calculated parameter as a discriminator for the first population and the second population.
2 . The method of claim 1 , wherein at least the first population and the second population comprise two patient populations.
3 . The method of claim 1 , wherein the first population comprises a healthy control group and the second population comprises an ischemic population.
4 . The method of claim 1 , wherein measuring blood perfusion as a function of time comprises using an optical measurement method.
5 . The method of claim 4 , wherein the optical method is diffuse correlation spectroscopy.
6 . The method of claim 4 , wherein the optical method is diffuse speckle contrast analysis.
7 . The method of claim 4 , wherein the optical method is diffuse optical tomography.
8 . The method of claim 4 , wherein the optical method is near-infrared spectroscopy.
9 . The method of claim 4 , wherein the optical method is laser Doppler flowmetry.
10 . The method of claim 1 , wherein measuring blood perfusion as a function of time comprises using a non-optical measurement method.
11 . The method of claim 10 , wherein the non-optical measurement method is selected from the group consisting of an electrical measurement method and a magnetic measurement method.
12 . The method of claim 1 , wherein measuring blood perfusion as a function of time comprises using an electrical or magnetic measurement method.
13 . The method of claim 1 , wherein mathematically transforming the time series data into a power spectrum comprises using a Fourier transform.
14 . The method of claim 1 , wherein mathematically transforming the time series data into a power spectrum comprises using a fast Fourier Transform.
15 . The method of claim 1 , wherein mathematically transforming the time series data into a power spectrum comprises using a wavelet transform.
16 . The method of claim 1 , wherein the specific frequency range is between about 0.001 Hz and about 1000 Hz.
17 . The method of claim 1 , wherein the specific frequency range is between about 0.001 Hz and about 0.1 Hz.
18 . The method of claim 1 , wherein the specific frequency range is between about 0.045 Hz and about 0.1 Hz.
19 . The method of claim 1 , wherein the frequency range of interest is between 0.001 Hz and 0.045 Hz.
20 . The method of claim 1 , wherein the at least one parameter is the area under the curve of the power spectrum within the specific frequency range.Join the waitlist — get patent alerts
Track US2020093382A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.